Evidence map›Paper›PMID 35450861›Full record

ArticleBMJ global health2022

Building a national framework for multicentre research and clinical trials: experience from the Nigeria Implementation Science Alliance.

John Olajide Olawepo, Echezona Edozie Ezeanolue, Adanma Ekenna, Olabanjo O Ogunsola, Ijeoma Uchenna Itanyi, Elima Jedy-Agba, Emmanuel Egbo, Chukwudi Onwuchekwa, Alexandra Ezeonu, Abiola Ajibola and 19 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

John Olajide OlawepoDepartment of Health Sciences, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0001-6732-1042
Echezona Edozie EzeanolueCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria eezeanolue@gmail.com.
Adanma EkennaCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Olabanjo O OgunsolaAPIN Public Health Initiatives, Abuja, FCT, Nigeria.ORCID 0000-0001-9601-0518
Ijeoma Uchenna ItanyiCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Elima Jedy-AgbaInstitute of Human Virology Nigeria, Abuja, FCT, Nigeria.
Emmanuel EgboCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Chukwudi OnwuchekwaCaritas Nigeria, Abuja, FCT, Nigeria.
Alexandra EzeonuCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Abiola AjibolaCenter for Integrated Health Programs (CIHP), Abuja, FCT, Nigeria.
Babayemi O OlakundeCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Omololuoye MajekodunmiFHI360, Abuja, FCT, Nigeria.
Amaka G OgidiCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
JohnBosco ChukwuorjiCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Nwamaka LasebikanCenter for Translation and Implementation Research (CTAIR), University of Nigeria, Nsukka, Enugu, Nigeria.
Patrick DakumInstitute of Human Virology Nigeria, Abuja, FCT, Nigeria.
Prosper OkonkwoAPIN Public Health Initiatives, Abuja, FCT, Nigeria.
Bolanle OyeledunCenter for Integrated Health Programs (CIHP), Abuja, FCT, Nigeria.
John OkoCaritas Nigeria, Abuja, FCT, Nigeria.
Hadiza KhamofuFHI360, Abuja, FCT, Nigeria.
Akudo IkpeazuNational AIDS, Viral Hepatitis and Sexually Transmitted Infections Control Programme, Federal Ministry of Health, Abuja, FCT, Nigeria.
Uchechukwu Emmanuel NwokwuNational Cancer Control Programme, Federal Ministry of Health, Abuja, FCT, Nigeria.
Gambo AliyuNational Agency for the Control of AIDS (NACA), Abuja, FCT, Nigeria.
Oladapo ShittuFederal University of Health Sciences Otukpo, Otukpo, Benue State, Nigeria.
Anne F RositchDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Byron J PowellCenter for Mental Health Services Research, Brown School at Washington University in St Louis, St Louis, Missouri, USA.
Donaldson F ConserveDepartment of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.ORCID 0000-0001-8193-817X
Gregory A AaronsDepartment of Psychiatry, University of California, San Diego, La Jolla, California, USA.
Ayodotun OlutolaCenter for Clinical Care and Clinical Research, Abuja, FCT, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is limited capacity and infrastructure in sub-Saharan Africa to conduct clinical trials for the identification of efficient and effective new prevention, diagnostic and treatment modalities to address the disproportionate burden of disease. This paper reports on the process to establish locally driven infrastructure for multicentre research and trials in Nigeria known as the Nigeria Implementation Science Alliance Model Innovation and Research Centres (NISA-MIRCs). We used a participatory approach to establish a research network of 21 high-volume health facilities selected from all 6 geopolitical zones in Nigeria capable of conducting clinical trials, implementation research using effectiveness-implementation hybrid designs and health system research. The NISA-MIRCs have a cumulative potential to recruit 60 000 women living with HIV and an age-matched cohort of HIV-uninfected women. We conducted a needs assessment, convened several stakeholder outreaches and engagement sessions, and established a governance structure. Additionally, we selected and trained a core research team, developed criteria for site selection, assessed site readiness for research and obtained ethical approval from a single national institutional review board. We used the Exploration, Preparation, Implementation, Sustainment framework to guide our reporting of the process in the development of this network. The NISA-MIRCs will provide a nationally representative infrastructure to initiate new studies, support collaborative research, inform policy decisions and thereby fill a significant research infrastructure gap in Africa's most populous country.

Indexed as

HIV InfectionsImplementation ScienceAfrica South of the SaharaFemaleHumansMaleNigeriaClinical trialCohort studyHIVMaternal healthPublic Health

Identifiers

PMID35450861
PMCPMC9024272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.